| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CHIMERIX INC | 565,000 | 21,295,000 | 9.89% | ||
| 2 | CEMPRA INC | 500,000 | 17,155,000 | 7.96% | ||
| 3 | ARIAD PHARMACEUTICALS INC | 1,500,000 | 12,360,000 | 5.74% | ||
| 4 | RETROPHIN INC COM | 500,000 | 11,980,000 | 5.56% | ||
| 5 | CLOVIS ONCOLOGY INC | 140,000 | 10,392,000 | 4.82% | ||
| 6 | AMAG PHARMACEUTICALS INC COM | 190,000 | 10,385,000 | 4.82% | ||
| 7 | AGIOS PHARMACEUTICALS INC | 90,000 | 8,487,000 | 3.94% | ||
| 8 | CODEXIS INC | 1,724,000 | 7,861,000 | 3.65% | ||
| 9 | GERON CORP | 1,825,000 | 6,880,000 | 3.19% | ||
| 10 | MEDGENICS INC | 850,000 | 6,851,000 | 3.18% | ||
| 11 | ULTRAGENYX PHARMACEUTICAL INC COM | 110,000 | 6,830,000 | 3.17% | ||
| 12 | SUPERNUS PHARMACEUTICALS INC COM | 535,000 | 6,468,000 | 3.00% | ||
| 13 | TETRAPHASE PHARMACEUTICALS I COM | 175,000 | 6,412,000 | 2.98% | ||
| 14 | INSYS THERAPEUTICS INC NEW COM NEW | 110,000 | 6,394,000 | 2.97% | ||
| 15 | MIMEDX GROUP INC COM | 590,000 | 6,136,000 | 2.85% | ||
| 16 | FIBROGEN INC COM | 191,338 | 6,004,000 | 2.79% | ||
| 17 | NEUROCRINE BIOSCIE COM USD0.001 | 145,000 | 5,758,000 | 2.67% | ||
| 18 | IMPRIMIS PHARMACEUTICALS INC | 687,100 | 5,490,000 | 2.55% | ||
| 19 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 300,000 | 5,394,000 | 2.50% | ||
| 20 | TRILLIUM THERAPEUTICS INC | 260,000 | 5,260,000 | 2.44% | ||
| 21 | OPHTHOTECH CORP COM | 105,000 | 4,886,000 | 2.27% | ||
| 22 | ADAMAS PHARMACEUTICALS INC | 255,000 | 4,460,000 | 2.07% | ||
| 23 | KITE PHARMA INCORPORATED | 76,000 | 4,384,000 | 2.04% | ||
| 24 | AMARIN CORP PLC | 1,754,000 | 4,104,000 | 1.91% | ||
| 25 | AXOGEN INC | 985,900 | 3,451,000 | 1.60% | ||
| 26 | CARA THERAPEUTICS INC | 315,000 | 3,166,000 | 1.47% | ||
| 27 | ZS PHARMA INC | 75,000 | 3,156,000 | 1.47% | ||
| 28 | Lion Biotechnologies | 200,000 | 2,422,000 | 1.12% | ||
| 29 | ACCELERATE DIAGNOSTICS INC | 100,600 | 2,264,000 | 1.05% | ||
| 30 | TENAX THERAPEUTICS INC COM | 606,200 | 1,976,000 | 0.92% | ||
| 31 | Evoke Pharma Inc | 245,000 | 1,727,000 | 0.80% | ||
| 32 | MACROGENICS INC | 50,000 | 1,569,000 | 0.73% | ||
| 33 | BioDelivery Sciences International Inc | 140,500 | 1,475,000 | 0.68% | ||
| 34 | CELGENE CORP | 490,000 | 1,455,000 | 0.68% | ||
| 35 | BIOLINERX LTD | 250,000 | 528,000 | 0.25% | ||
| 36 | INSPIREMD INC | 1,250,000 | 400,000 | 0.19% | ||
| 37 | Tracon Pharmaceuticals Inc | 12,172 | 171,000 | 0.08% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001546927-15-000149, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
